Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Biocides; animal or insect repellents or attractants
Reexamination Certificate
2002-11-08
2010-10-12
Wax, Robert A (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Biocides; animal or insect repellents or attractants
Reexamination Certificate
active
07811599
ABSTRACT:
Medical combination and its method of topical use comprising active ingredients which are sparingly soluble in water, preferably in one single composition against microbes which are pathogenic in humans and animals and which usually appear together. It comprises at least one active ingredient which is effective against several of the opportunally pathogenic strains of the group consisting of fungiCandida, Aspergillus, and/orFusarium, and aerobic bacteria: Gram-negative bacilli such asProteus, Pseudomonas, enterobacterspecies,Escherichia coli, Klebsiella, Serratia marcescens, Citrobacter, Aeromonas; Gram-negative cocci such asNeisseria, Acinetobacterspecies; Gram-positive bacilli such asCorynebacteriumspecies,Bacillus sphaericus, Gram-positive cocci such asStreptococcusspecies; anaerobic bacteria: Gram-negative cocci such asBacteroides, Fusobacteria; Gram-positive cocci such asPeptococcus, Peptostreptococcusspecies; Gram-positive bacilli such asClostridium, Propionibacterium, Eubacteriumspecies andMycobacteriumspecies such asMycobacterium ulcerans, microbes similar to bacteria of theChlamydiaspecies such asChlamydia trachomatis. To be used for treatment of the skin or mucous membranes bearing epithelial lesions, deficiency or injuries and to be used in body cavities to prevent or cure infections and deficiencies. The composition contains-dispersed in a carrier which is pharmaceutically acceptable on the site of treatment-at least one fungicide, which is preferably azole or polyene type and at least one antibacterial compound preferably of the erythromycin, azalide, linkozamide, polypeptide type and at least one bacteriostatic sulphonamide. Additionals mainly for use on skin may include zinc oxide and asulene. Useful in forms of ointment, tablet, effervescent tablet, suppository, foam.
REFERENCES:
patent: 4466961 (1984-08-01), Szijjarto nee Auber
patent: 4601905 (1986-07-01), Szeles
patent: 4912124 (1990-03-01), Das et al.
patent: 0 125 759 (1991-09-01), None
patent: 54 140712 (1979-11-01), None
patent: EP 1 206 937 (2000-07-01), None
patent: WO 96/03135 (1996-02-01), None
patent: WO 98/44914 (1998-10-01), None
Physicians'Desk Reference, 49thEd. (1995); p. 1809.
Welsh et al. “In Vitro Evaluation of Activities of Azithromycin, Erythromycin, and Tetracycline against Chlamydia trachomatis and Chlamydia pneumoniae”, Antimicrobial Agents and Chemotherapy, Feb. 1992, vol. 36, No. 2; pp. 291-294.
MSDS for miconazole nitrate.
Schmidt K, Bacterial population of chronic crural ulcers: is there a difference between the diabetic, the venous, and the arterial ulcer?, VASA, Feb. 2000, 29(1):62-70, Chirurgische Klinik and Poliklinik, Universität Würzburg, Germany.
Up-to-date Medical Diagnostics and Therapy Officina Nova 1990. pp. 1160 to 1166.
Appleton & Lange Current Medical Diagnosis & Treatment 1996 p. 146, 147, 1336.
International Search Report for International Publication No. PCT/HU02/00115. Date of Mailing: Mar. 6, 2003.
Dajka Levente
Hegedüs Lajos
Krempels Krisztina
Lukács Károly
Lukács Károlyné
Lukacs Karoly
Palenik Jeffrey T
Pearl Cohen Zedek Latzer LLP
Wax Robert A
LandOfFree
Pharmaceutical combinations comprising a fungicide, a... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical combinations comprising a fungicide, a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical combinations comprising a fungicide, a... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4210512